Unveiling of 3 new drugs of Actoverco Company among the neurology group
On December 26, 2019, during a glorious ceremony attended by more than 180 psychiatrists and neurologists, three new drugs of Actoverco Company were officially unveiled.
Explanation of the manufacturer of the news-making drug “Losartan”
Following the Food and Drug Administration’s order to collect Losartan drug with Indian active ingredient from the supply level, the Iranian company “Actoverco” announced in a statement that it has issued an immediate stop order to sell Losartan drug to distribution companies and the drug collection process from the pharmacies has started.
Senior Lebanese officials visit from the Actover Group factories
Adviser of the Lebanese Minister of Health, at the head of a high-level delegation of senior officials of this ministry, while visiting the factories of Actover Pharmaceutical Group and the greatest oncology drugs production site in Iran and the region, emphasized on the expansion of Iran-Lebanon pharmaceutical cooperation.
Vague comments about drug monopolies
Homayoun Hashemi, the head of the Food and Drug Faction, said at the inauguration ceremony of the new Actoverco Solid Drug Production Factory : “Some existing monopolies in the field of medicine must be broken.
We did not shout a slogan, we acted
The CEO of the Actover Pharmaceutical Group at the opening ceremony of the new Actoverco Solid Drug Production Plant said: “Currently, there are about 3000 people working in the Actover Pharmaceutical Group, 90% of whom are under 40 years old.”